Followers | 0 |
Posts | 13277 |
Boards Moderated | 0 |
Alias Born | 05/06/2016 |
Tuesday, December 20, 2016 11:18:20 PM
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=160529
Item 1: Completion of Disposition of Assets
On August 22, 2016, it was announced that Manzo Pharmaceuticals CEO Kenneth Manzo Milford, the Issuer's Chief Executive Officer resigned in connection with a settlement with the U.S. Securities and Exchange Commission (SEC). The SEC settlement bars Mr. Manzo from being an officer or director of the Issuer.
The Issuer was dependent upon the personal financial support of Mr. Manzo, who had never taken any salary. The Issuer cannot develop its business plan without the services and funding of Mr. Manzo. Therefore, the Issuer has conveyed Manzo Pharmaceuticals, LLC back to Mr. Manzo in exchange for all of Mr. Manzo's common stock in the Issuer, two hundred million shares. This transfer leaves the Issuer without operations or a material amount of assets.
At present, the Issuer intends to start to study ways to increase shareholder value. There is no assurance that the Issuer will be successful in this endeavor.
Item 2: Changes in Control of Issuer
In connection with Mr. Manzo's departure from the Issuer, Mr. Manzo sold his Preferred stock in the Issuer. The 4,000,000 shares of Series A Preferred Stock formerly owned by Mr. Manzo is now owned by Gerasimos Alexander Antonios Morfesis.
Item 3: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
The Issuer has accepted Mr. Manzo's resignation as an officer and director of the Issuer. The 4,000,000 shares of Manzo Pharmaceuticals, Inc. Series A Preferred Stock have been conveyed to Gerasimos Alexander Antonios Morfesis.
Mr. Morfesis' address is 385 Whitcomb Boulevard, Tarpon Springs, Florida 34689. Mr. Morfesis is a real estate investor.
It is strange that nothing can be found on the SEC’s website.
A search for "manzo" finds 10 items stretching back to 2002, and none of them are Kenneth Manzo.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM